TIDMSHP
Director/PDMR Shareholding
January 8, 2019 -- Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company")
Notification of transactions by persons discharging managerial
responsibilities
Details of the person discharging managerial responsibilities
1. ("PDMR") / person closely associated with them ("PCA")
---- ------------------------------------------------------------------------------------------------
a) Name Flemming Ornskov
---- ----------------------------- -----------------------------------------------------------------
2. Reason for the notification
---- ------------------------------------------------------------------------------------------------
a) Position / status Chief Executive Officer - PDMR
---- ----------------------------- -----------------------------------------------------------------
Initial notification /
b) amendment Initial notification
---- ----------------------------- -----------------------------------------------------------------
Details of the issuer, emission allowance participant,
3. auction platform, auctioneer or auction monitor
---- ------------------------------------------------------------------------------------------------
a) Name Shire plc
---- ----------------------------- -----------------------------------------------------------------
b) LEI 54930005LQRLI2UXRQ59
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
4. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Portfolio Share Plan ("PSP") on February
28, 2013. In accordance with the rules of the PSP
and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited dated May
8, 2018, exercise of the SARs is to be satisfied in
cash in an amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 95.04 45,601
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
5. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Portfolio Share Plan ("PSP") on May
2, 2013. In accordance with the rules of the PSP and
the Co-Operation Agreement between the Company and
Takeda Pharmaceutical Company Limited dated May 8,
2018, exercise of the SARs is to be satisfied in cash
in an amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 91.59 18,984
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
6. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Portfolio Share Plan ("PSP") on February
28, 2014. In accordance with the rules of the PSP
and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited dated May
8, 2018, exercise of the SARs is to be satisfied in
cash in an amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 168.54 34,174
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
7. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Voluntary cancellation of Stock Appreciation Rights
("SARs") awarded under the Shire Long Term Incentive
Plan 2015 on April 30, 2015, in consideration of a
cash payment from the Company per ADS subject to the
SAR, net of any necessary deductions for tax and social
security contributions, in accordance with the Co-Operation
Agreement between the Company and Takeda Pharmaceutical
b) Nature of the transaction Company Limited dated May 8, 2018.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 7.69 10,031
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
8. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 26, 2016. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the SARs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. applicable performance conditions were achieved at a
level of 100%;
3. exercise of the SARs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 161.42 43,329
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
9. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 26, 2016. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. applicable performance conditions were achieved at a
level of 100%;
3. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
4. vesting of the PSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 33,023
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
10. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 11, 2016. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 4,313
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
11. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Voluntary cancellation of Stock Appreciation Rights
("SARs") awarded under the Shire Long Term Incentive
Plan 2015 on February 28, 2017, in consideration of
a cash payment from the Company per ADS subject to
the SAR, net of any necessary deductions for tax and
social security contributions, in accordance with
the Co-Operation Agreement between the Company and
Takeda Pharmaceutical Company Limited dated May 8,
2018. The number of SARs outstanding prior to cancellation
was reduced to reflect the the achievement of applicable
b) Nature of the transaction performance conditions at a level of 87%.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 5.69 26,566
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
12. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 28, 2017. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of PSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date and the achievement of applicable
performance conditions at a level of 87%;
3. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
4. vesting of the PSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 13,441
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
13. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 10, 2017. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 3,765
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
14. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 9, 2018. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 3,512
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
15. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on May 1, 2018. In accordance with the rules of the
LTIP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of PSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date;
3. applicable performance conditions were achieved at a
level of 100%;
4. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
5. vesting of the PSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 14,941
---- ----------------------------- ------- -------------- ----------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume - Price
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the person discharging managerial responsibilities
1. ("PDMR") / person closely associated with them ("PCA")
--- -------------------------------------------------------------------------------------------------
a) Name Thomas Dittrich
--- ----------------------------- ------------------------------------------------------------------
2. Reason for the notification
--- -------------------------------------------------------------------------------------------------
a) Position / status Chief Financial Officer - PDMR
--- ----------------------------- ------------------------------------------------------------------
Initial notification /
b) amendment Initial notification
--- ----------------------------- ------------------------------------------------------------------
Details of the issuer, emission allowance participant,
3. auction platform, auctioneer or auction monitor
--- -------------------------------------------------------------------------------------------------
a) Name Shire plc
--- ----------------------------- ------------------------------------------------------------------
b) LEI 54930005LQRLI2UXRQ59
--- ----------------------------- ------------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
4. where transactions have been conducted
--- -------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
---
a) Identification code ISIN: JE00B2QKY057
--- ----------------------------- ------------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on March 29, 2018. In accordance with the rules of
the LTIP and the Co-Operation Agreement between the
Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of PSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date;
3. applicable performance conditions were achieved at a
level of 100%;
4. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
5. vesting of the PSUs is to be satisfied in cash in an
amount per Ordinary Share of GBP47.12, net of any
necessary deductions for tax and social security
b) Nature of the transaction contributions.
--- ----------------------------- ------------------------------------------------------------------
Price(s) Volume(s)
--- ----------------------------- ------------------------ ----------------------------------------
c) Price(s) and volume(s) GBP 0 2,544
--- ----------------------------- --------- ------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
--- ----------------------------- ------------------------------------------------------------------
e) Date of the transaction January 3, 2019
--- ----------------------------- ------------------------------------------------------------------
f) Place of the transaction N/A
--- ----------------------------- ------------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
5. where transactions have been conducted
--- -------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
---
a) Identification code ISIN: JE00B2QKY057
--- ----------------------------- ------------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on May 1, 2018. In accordance with the rules of the
LTIP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of PSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date;
3. applicable performance conditions were achieved at a
level of 100%;
4. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
vesting of the PSUs is to be satisfied in cash in
an amount per Ordinary Share of GBP47.12, net of any
b) Nature of the transaction necessary deductions for tax and social security contributions.
--- ----------------------------- ------------------------------------------------------------------
Price(s) Volume(s)
--- ----------------------------- ------------------------ ----------------------------------------
c) Price(s) and volume(s) GBP 0 16,854
--- ----------------------------- --------- ------------- ----------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume - Price
--- ----------------------------- ------------------------------------------------------------------
e) Date of the transaction January 3, 2019
--- ----------------------------- ------------------------------------------------------------------
f) Place of the transaction N/A
--- ----------------------------- ------------------------------------------------------------------
Details of the person discharging managerial responsibilities
1. ("PDMR") / person closely associated with them ("PCA")
--- -----------------------------------------------------------------------------------------------
a) Name Andy Busch
--- ----------------------------- ----------------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------------------------------------------
Head of Research and Development and Chief Scientific
a) Position / status Officer - PDMR
--- ----------------------------- ----------------------------------------------------------------
Initial notification /
b) amendment Initial notification
--- ----------------------------- ----------------------------------------------------------------
Details of the issuer, emission allowance participant,
3. auction platform, auctioneer or auction monitor
--- -----------------------------------------------------------------------------------------------
a) Name Shire plc
--- ----------------------------- ----------------------------------------------------------------
b) LEI 54930005LQRLI2UXRQ59
--- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
4. where transactions have been conducted
--- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
---
a) Identification code ISIN: JE00B2QKY057
--- ----------------------------- ----------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on March 1, 2018. In accordance with the rules of
the LTIP and the Co-Operation Agreement between the
Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting dates resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting dates;
3. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
4. vesting of the RSUs is to be satisfied in cash in an
amount per Ordinary Share of GBP47.12, net of any
necessary deductions for tax and social security
b) Nature of the transaction contributions.
--- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
--- ----------------------------- ------------------------ --------------------------------------
c) Price(s) and volume(s) GBP 0 7,628
--- ----------------------------- --------- ------------- --------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
--- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
--- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
--- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
5. where transactions have been conducted
--- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
---
a) Identification code ISIN: JE00B2QKY057
--- ----------------------------- ----------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on March 1, 2018. In accordance with the rules of
the LTIP and the Co-Operation Agreement between the
Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the SARs was accelerated relative to the
normal vesting dates resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of SARs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date;
3. exercise of the SARs is to be satisfied in cash in an
amount per Ordinary Share of GBP47.12, net of any
necessary deductions for tax and social security
b) Nature of the transaction contributions.
--- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
--- ----------------------------- ------------------------ --------------------------------------
c) Price(s) and volume(s) GBP 31.29 11,132
--- ----------------------------- --------- ------------- --------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
--- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
--- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
--- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
6. where transactions have been conducted
--- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
---
a) Identification code ISIN: JE00B2QKY057
--- ----------------------------- ----------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on May 1, 2018. In accordance with the rules of the
LTIP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of PSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date;
3. applicable performance conditions were achieved at a
level of 100%;
4. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
5. vesting of the PSUs is to be satisfied in cash in an
amount per Ordinary Share of GBP47.12, net of any
necessary deductions for tax and social security
b) Nature of the transaction contributions.
--- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
--- ----------------------------- ------------------------ --------------------------------------
c) Price(s) and volume(s) GBP 0 12,584
--- ----------------------------- --------- ------------- --------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume - Price
--- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
--- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
--- ----------------------------- ----------------------------------------------------------------
Details of the person discharging managerial responsibilities
1. ("PDMR") / person closely associated with them ("PCA")
---- ---------------------------------------------------------------------------------------------------
a) Name Joanne Cordeiro
---- ----------------------------- --------------------------------------------------------------------
2. Reason for the notification
---- ---------------------------------------------------------------------------------------------------
a) Position / status Chief Human Resources Officer - PDMR
---- ----------------------------- --------------------------------------------------------------------
Initial notification /
b) amendment Initial notification
---- ----------------------------- --------------------------------------------------------------------
Details of the issuer, emission allowance participant,
3. auction platform, auctioneer or auction monitor
---- ---------------------------------------------------------------------------------------------------
a) Name Shire plc
---- ----------------------------- --------------------------------------------------------------------
b) LEI 54930005LQRLI2UXRQ59
---- ----------------------------- --------------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
4. where transactions have been conducted
---- ---------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- --------------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Portfolio Share Plan ("PSP") on February
28, 2014. In accordance with the rules of the PSP
and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018, exercise of the SARs is to be satisfied
in cash in an amount per ADS of $173.17, net of any
b) Nature of the transaction necessary deductions for tax and social security contributions.
---- ----------------------------- --------------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ------------------------- -----------------------------------------
c) Price(s) and volume(s) $ 168.54 772
---- ----------------------------- -------- --------------- -----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- --------------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- --------------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- --------------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
5. where transactions have been conducted
---- ---------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- --------------------------------------------------------------------
Voluntary cancellation of Stock Appreciation Rights
("SARs") awarded under the Shire Long Term Incentive
Plan 2015 on February 27, 2015, in consideration of
a cash payment from the Company per ADS subject to
the SAR, net of any necessary deductions for tax and
social security contributions, in accordance with
the Co-Operation Agreement between the Company and
Takeda Pharmaceutical Company Limited dated May 8,
b) Nature of the transaction 2018.
---- ----------------------------- --------------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ------------------------- -----------------------------------------
c) Price(s) and volume(s) $ 7.68 1,934
---- ----------------------------- -------- --------------- -----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- --------------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- --------------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- --------------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
6. where transactions have been conducted
---- ---------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- --------------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 26, 2016. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of certain of the SARs was accelerated
relative to the normal vesting dates resultant of the
Royal Court of Jersey's sanctioning of the scheme of
arrangement governing the acquisition of the Company
by Takeda;
2. exercise of the SARs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- --------------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ------------------------- -----------------------------------------
c) Price(s) and volume(s) $ 161.42 3,495
---- ----------------------------- -------- --------------- -----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- --------------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- --------------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- --------------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
7. where transactions have been conducted
---- ---------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- --------------------------------------------------------------------
Voluntary cancellation of Stock Appreciation Rights
("SARs") awarded under the Shire Long Term Incentive
Plan 2015 on February 28, 2017, in consideration of
a cash payment from the Company per ADS subject to
the SAR, net of any necessary deductions for tax and
social security contributions, in accordance with
the Co-Operation Agreement between the Company and
Takeda Pharmaceutical Company Limited dated May 8,
b) Nature of the transaction 2018.
---- ----------------------------- --------------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ------------------------- -----------------------------------------
c) Price(s) and volume(s) $ 5.69 3,896
---- ----------------------------- -------- --------------- -----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- --------------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- --------------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- --------------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
8. where transactions have been conducted
---- ---------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- --------------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 28, 2017. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of PSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date and the achievement of applicable
performance conditions at a level of 87%;
3. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
4. vesting of the PSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- --------------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ------------------------- -----------------------------------------
c) Price(s) and volume(s) $ 0 346
---- ----------------------------- -------- --------------- -----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- --------------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- --------------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- --------------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
9. where transactions have been conducted
---- ---------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- --------------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 28, 2017. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date;
3. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
4. vesting of the RSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- --------------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ------------------------- -----------------------------------------
c) Price(s) and volume(s) $ 0 139
---- ----------------------------- -------- --------------- -----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- --------------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- --------------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- --------------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
10. where transactions have been conducted
---- ---------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- --------------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on August 24, 2017. In accordance with the rules of
the LTIP and the Co-Operation Agreement between the
Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date;
3. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
4. vesting of the RSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- --------------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ------------------------- -----------------------------------------
c) Price(s) and volume(s) $ 0 939
---- ----------------------------- -------- --------------- -----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- --------------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- --------------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- --------------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
11. where transactions have been conducted
---- ---------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- --------------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 9, 2018. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- --------------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ------------------------- -----------------------------------------
c) Price(s) and volume(s) $ 0 825
---- ----------------------------- -------- --------------- -----------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume - Price
---- ----------------------------- --------------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- --------------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- --------------------------------------------------------------------
Details of the person discharging managerial responsibilities
1. ("PDMR") / person closely associated with them ("PCA")
---- ----------------------------------------------------------------------------------------------
a) Name Bill Mordan
---- ----------------------------- ---------------------------------------------------------------
2. Reason for the notification
---- ----------------------------------------------------------------------------------------------
a) Position / status General Counsel and Company Secretary - PDMR
---- ----------------------------- ---------------------------------------------------------------
Initial notification /
b) amendment Initial notification
---- ----------------------------- ---------------------------------------------------------------
Details of the issuer, emission allowance participant,
3. auction platform, auctioneer or auction monitor
---- ----------------------------------------------------------------------------------------------
a) Name Shire plc
---- ----------------------------- ---------------------------------------------------------------
b) LEI 54930005LQRLI2UXRQ59
---- ----------------------------- ---------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
4. where transactions have been conducted
---- ----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- ---------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 12, 2016. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the SARs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. exercise of the SARs is to be satisfied in cash in an
amount per ADS $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- ---------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- --------------------- ----------------------------------------
c) Price(s) and volume(s) $ 154.95 6,147
---- ----------------------------- ------ ------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ---------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ---------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ---------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
5. where transactions have been conducted
---- ----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- ---------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 26, 2016. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the SARs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. exercise of the SARs is to be satisfied in cash in an
amount per ADS $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- ---------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- --------------------- ----------------------------------------
c) Price(s) and volume(s) $ 161.42 9,680
---- ----------------------------- ------ ------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ---------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ---------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ---------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
6. where transactions have been conducted
---- ----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- ---------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 11, 2016. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- ---------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- --------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 157
---- ----------------------------- ------ ------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ---------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ---------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ---------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
7. where transactions have been conducted
---- ----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- ---------------------------------------------------------------
Voluntary cancellation of Stock Appreciation Rights
("SARs") awarded under the Shire Long Term Incentive
Plan 2015 on February 28, 2017, in consideration of
a cash payment from the Company per ADS subject to
the SAR, net of any necessary deductions for tax and
social security contributions, in accordance with
the Co-Operation Agreement between the Company and
Takeda Pharmaceutical Company Limited dated May 8,
b) Nature of the transaction 2018.
---- ----------------------------- ---------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- --------------------- ----------------------------------------
c) Price(s) and volume(s) $ 5.69 9,415
---- ----------------------------- ------ ------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ---------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ---------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ---------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
8. where transactions have been conducted
---- ----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- ---------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 28, 2017. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of PSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date and the achievement of applicable
performance conditions at a level of 87%;
3. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
4. vesting of the PSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- ---------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- --------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 5,140
---- ----------------------------- ------ ------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ---------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ---------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ---------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
9. where transactions have been conducted
---- ----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- ---------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 10, 2017. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- ---------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- --------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 869
---- ----------------------------- ------ ------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ---------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ---------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ---------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
10. where transactions have been conducted
---- ----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- ---------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 9, 2018. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- ---------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- --------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 1,039
---- ----------------------------- ------ ------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ---------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ---------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ---------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
11. where transactions have been conducted
---- ----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- ---------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on May 1, 2018. In accordance with the rules of the
LTIP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of PSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date;
3. applicable performance conditions were achieved at a
level of 100%;
4. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
5. vesting of the PSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- ---------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- --------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 5,060
---- ----------------------------- ------ ------------- ----------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume - Price
---- ----------------------------- ---------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ---------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ---------------------------------------------------------------
Details of the person discharging managerial responsibilities
1. ("PDMR") / person closely associated with them ("PCA")
---- ------------------------------------------------------------------------------------------------
a) Name Perry Sternberg
---- ----------------------------- -----------------------------------------------------------------
2. Reason for the notification
---- ------------------------------------------------------------------------------------------------
a) Position / status Head of US Commercial - PDMR
---- ----------------------------- -----------------------------------------------------------------
Initial notification /
b) amendment Initial notification
---- ----------------------------- -----------------------------------------------------------------
Details of the issuer, emission allowance participant,
3. auction platform, auctioneer or auction monitor
---- ------------------------------------------------------------------------------------------------
a) Name Shire plc
---- ----------------------------- -----------------------------------------------------------------
b) LEI 54930005LQRLI2UXRQ59
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
4. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Portfolio Share Plan ("PSP") on February
28, 2014. In accordance with the rules of the PSP
and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited dated May
8, 2018, exercise of the SARs is to be satisfied in
cash in an amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 168.54 1,485
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
5. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Voluntary cancellation of Stock Appreciation Rights
("SARs") awarded under the Shire Long Term Incentive
Plan 2015 on February 27, 2015, in consideration of
a cash payment from the Company per ADS subject to
the SAR, net of any necessary deductions for tax and
social security contributions, in accordance with
the Co-Operation Agreement between the Company and
Takeda Pharmaceutical Company Limited dated May 8,
b) Nature of the transaction 2018.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 7.68 5,909
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
6. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 26, 2016. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of certain of the SARs was accelerated
relative to the normal vesting dates resultant of the
Royal Court of Jersey's sanctioning of the scheme of
arrangement governing the acquisition of the Company
by Takeda;
2. exercise of the SARs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 161.42 8,896
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
7. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Voluntary cancellation of Stock Appreciation Rights
("SARs") awarded under the Shire Long Term Incentive
Plan 2015 on February 28, 2017, in consideration of
a cash payment from the Company per ADS subject to
the SAR, net of any necessary deductions for tax and
social security contributions, in accordance with
the Co-Operation Agreement between the Company and
Takeda Pharmaceutical Company Limited dated May 8,
b) Nature of the transaction 2018.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 5.69 9,511
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
8. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 9, 2018. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 719
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
9. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on May 1, 2018. In accordance with the rules of the
LTIP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of PSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date;
3. applicable performance conditions were achieved at a
level of 100%;
4. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
5. vesting of the PSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 3,979
---- ----------------------------- ------- -------------- ----------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
10. where transactions have been conducted
---- ------------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
----
a) Identification code ISIN: US82481R1068
---- ----------------------------- -----------------------------------------------------------------
Vesting of Restricted Stock Award ("RSA") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 10, 2017. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSA was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. as a result of the vesting of the RSA, restrictions
applying to the applicable ADSs already held will
b) Nature of the transaction cease to apply.
---- ----------------------------- -----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- ----------------------- ----------------------------------------
c) Price(s) and volume(s) $ 0 530
---- ----------------------------- ------- -------------- ----------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume - Price
---- ----------------------------- -----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- -----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- -----------------------------------------------------------------
Details of the person discharging managerial responsibilities
1. ("PDMR") / person closely associated with them ("PCA")
---- -----------------------------------------------------------------------------------------------
a) Name Kim Stratton
---- ----------------------------- ----------------------------------------------------------------
2. Reason for the notification
---- -----------------------------------------------------------------------------------------------
a) Position / status Head of International Commercial - PDMR
---- ----------------------------- ----------------------------------------------------------------
Initial notification /
b) amendment Initial notification
---- ----------------------------- ----------------------------------------------------------------
Details of the issuer, emission allowance participant,
3. auction platform, auctioneer or auction monitor
---- -----------------------------------------------------------------------------------------------
a) Name Shire plc
---- ----------------------------- ----------------------------------------------------------------
b) LEI 54930005LQRLI2UXRQ59
---- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
4. where transactions have been conducted
---- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
----
a) Identification code ISIN: JE00B2QKY057
---- ----------------------------- ----------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Portfolio Share Plan ("PSP") on August
29, 2013. In accordance with the rules of the PSP
and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited dated May
8, 2018, exercise of the SARs is to be satisfied in
cash in an amount per Ordinary Share of GBP47.12,
net of any necessary deductions for tax and social
b) Nature of the transaction security contributions.
---- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- -------------------------- ------------------------------------
c) Price(s) and volume(s) GBP 24.00 9,787
---- ----------------------------- ---------- -------------- ------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
5. where transactions have been conducted
---- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
----
a) Identification code ISIN: JE00B2QKY057
---- ----------------------------- ----------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Portfolio Share Plan ("PSP") on February
28, 2014. In accordance with the rules of the PSP
and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited dated May
8, 2018, exercise of the SARs is to be satisfied in
cash in an amount per Ordinary Share of GBP47.12,
net of any necessary deductions for tax and social
b) Nature of the transaction security contributions.
---- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- -------------------------- ------------------------------------
c) Price(s) and volume(s) GBP 33.83 6,590
---- ----------------------------- ---------- -------------- ------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
6. where transactions have been conducted
---- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
----
a) Identification code ISIN: JE00B2QKY057
---- ----------------------------- ----------------------------------------------------------------
Voluntary cancellation of Stock Appreciation Rights
("SARs") awarded under the Shire Long Term Incentive
Plan 2015 on February 27, 2015, in consideration of
a cash payment from the Company per Ordinary Share
subject to the SAR, net of any necessary deductions
for tax and social security contributions, in accordance
with the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited dated May
b) Nature of the transaction 8, 2018.
---- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- -------------------------- ------------------------------------
c) Price(s) and volume(s) GBP 1.65 12,623
---- ----------------------------- ---------- -------------- ------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
7. where transactions have been conducted
---- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
----
a) Identification code ISIN: JE00B2QKY057
---- ----------------------------- ----------------------------------------------------------------
Exercise of Stock Appreciation Rights ("SARs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 26, 2016. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of certain of the SARs was accelerated
relative to the normal vesting date resultant of the
Royal Court of Jersey's sanctioning of the scheme of
arrangement governing the acquisition of the Company
by Takeda;
2. exercise of the SARs is to be satisfied in cash in an
amount per Ordinary Share of GBP47.12, net of any
necessary deductions for tax and social security
b) Nature of the transaction contributions.
---- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- -------------------------- ------------------------------------
c) Price(s) and volume(s) GBP 38.50 15,086
---- ----------------------------- ---------- -------------- ------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
8. where transactions have been conducted
---- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
----
a) Identification code ISIN: JE00B2QKY057
---- ----------------------------- ----------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 26, 2016. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. applicable performance conditions were achieved at a
level of 100%;
3. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
4. vesting of the PSUs is to be satisfied in cash in an
amount per Ordinary Share of GBP47.12, net of any
necessary deductions for tax and social security
b) Nature of the transaction contributions.
---- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- -------------------------- ------------------------------------
c) Price(s) and volume(s) GBP 0 2,136
---- ----------------------------- ---------- -------------- ------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
9. where transactions have been conducted
---- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
----
a) Identification code ISIN: JE00B2QKY057
---- ----------------------------- ----------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 26, 2016. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per Ordinary Share GBP47.12, net of any
necessary deductions for tax and social security
b) Nature of the transaction contributions.
---- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- -------------------------- ------------------------------------
c) Price(s) and volume(s) GBP 0 748
---- ----------------------------- ---------- -------------- ------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
10. where transactions have been conducted
---- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
----
a) Identification code ISIN: JE00B2QKY057
---- ----------------------------- ----------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on August 5, 2016. In accordance with the rules of
the LTIP and the Co-Operation Agreement between the
Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date(s) resultant of the Royal Court
of Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per Ordinary Share GBP47.12, net of any
necessary deductions for tax and social security
b) Nature of the transaction contributions.
---- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- -------------------------- ------------------------------------
c) Price(s) and volume(s) GBP 0 3113
---- ----------------------------- ---------- -------------- ------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
11. where transactions have been conducted
---- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
----
a) Identification code ISIN: JE00B2QKY057
---- ----------------------------- ----------------------------------------------------------------
Voluntary cancellation of Stock Appreciation Rights
("SARs") awarded under the Shire Long Term Incentive
Plan 2015 on February 28, 2017, in consideration of
a cash payment from the Company per Ordinary Share
subject to the SAR, net of any necessary deductions
for tax and social security contributions, in accordance
with the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited dated May
b) Nature of the transaction 8, 2018.
---- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- -------------------------- ------------------------------------
c) Price(s) and volume(s) GBP 1.52 26,587
---- ----------------------------- ---------- -------------- ------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
12. where transactions have been conducted
---- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
----
a) Identification code ISIN: JE00B2QKY057
---- ----------------------------- ----------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 28, 2017. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of PSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date and the achievement of applicable
performance conditions at a level of 87%;
3. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
4. vesting of the PSUs is to be satisfied in cash in an
amount per Ordinary Share of GBP47.12, net of any
necessary deductions for tax and social security
b) Nature of the transaction contributions.
---- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- -------------------------- ------------------------------------
c) Price(s) and volume(s) GBP 0 14,518
---- ----------------------------- ---------- -------------- ------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
13. where transactions have been conducted
---- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
----
a) Identification code ISIN: JE00B2QKY057
---- ----------------------------- ----------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 10, 2017. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per Ordinary Share of GBP47.12, net of any
necessary deductions for tax and social security
b) Nature of the transaction contributions.
---- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- -------------------------- ------------------------------------
c) Price(s) and volume(s) GBP 0 2,957
---- ----------------------------- ---------- -------------- ------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
14. where transactions have been conducted
---- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
----
a) Identification code ISIN: JE00B2QKY057
---- ----------------------------- ----------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 9, 2018. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date(s) resultant of the Royal Court
of Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per Ordinary Share of GBP47.12, net of any
necessary deductions for tax and social security
b) Nature of the transaction contributions.
---- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- -------------------------- ------------------------------------
c) Price(s) and volume(s) GBP 0 3,915
---- ----------------------------- ---------- -------------- ------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
---- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
15. where transactions have been conducted
---- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of Shire plc Ordinary Shares of 5 pence each ("Ordinary
instrument Shares")
----
a) Identification code ISIN: JE00B2QKY057
---- ----------------------------- ----------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on May 1, 2018. In accordance with the rules of the
LTIP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of PSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date;
3. applicable performance conditions were achieved at a
level of 100%;
4. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
5. vesting of the PSUs is to be satisfied in cash in an
amount per Ordinary Share of GBP47.12, net of any
necessary deductions for tax and social security
b) Nature of the transaction contributions.
---- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
---- ----------------------------- -------------------------- ------------------------------------
c) Price(s) and volume(s) GBP 0 13,488
---- ----------------------------- ---------- -------------- ------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume - Price
---- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
---- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
---- ----------------------------- ----------------------------------------------------------------
Details of the person discharging managerial responsibilities
1. ("PDMR") / person closely associated with them ("PCA")
--- -----------------------------------------------------------------------------------------------
a) Name Matt Walker
--- ----------------------------- ----------------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------------------------------------------
a) Position / status Head of Technical Operations - PDMR
--- ----------------------------- ----------------------------------------------------------------
Initial notification /
b) amendment Initial notification
--- ----------------------------- ----------------------------------------------------------------
Details of the issuer, emission allowance participant,
3. auction platform, auctioneer or auction monitor
--- -----------------------------------------------------------------------------------------------
a) Name Shire plc
--- ----------------------------- ----------------------------------------------------------------
b) LEI 54930005LQRLI2UXRQ59
--- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
4. where transactions have been conducted
--- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
---
a) Identification code ISIN: US82481R1068
--- ----------------------------- ----------------------------------------------------------------
Voluntary cancellation of Stock Appreciation Rights
("SARs") awarded under the Shire Long Term Incentive
Plan 2015 on May 2, 2016, in consideration of a cash
payment from the Company per ADS subject to the SAR,
net of any necessary deductions for tax and social
security contributions, in accordance with the Co-Operation
Agreement between the Company and Takeda Pharmaceutical
b) Nature of the transaction Company Limited dated May 8, 2018.
--- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
--- ----------------------------- ----------------------- ---------------------------------------
c) Price(s) and volume(s) $ 5.78 5,162
--- ----------------------------- ------- -------------- ---------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
--- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
--- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
--- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
5. where transactions have been conducted
--- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
---
a) Identification code ISIN: US82481R1068
--- ----------------------------- ----------------------------------------------------------------
Voluntary cancellation of Stock Appreciation Rights
("SARs") awarded under the Shire Long Term Incentive
Plan 2015 on February 28, 2017, in consideration of
a cash payment from the Company per ADS subject to
the SAR, net of any necessary deductions for tax and
social security contributions, in accordance with
the Co-Operation Agreement between the Company and
Takeda Pharmaceutical Company Limited dated May 8,
b) Nature of the transaction 2018.
--- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
--- ----------------------------- ----------------------- ---------------------------------------
c) Price(s) and volume(s) $ 5.69 8,179
--- ----------------------------- ------- -------------- ---------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
--- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
--- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
--- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
6. where transactions have been conducted
--- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
---
a) Identification code ISIN: US82481R1068
--- ----------------------------- ----------------------------------------------------------------
Vesting of Performance Stock Units ("PSUs") awarded
under the Shire Long Term Incentive Plan 2015 ("LTIP")
on February 28, 2017. In accordance with the rules
of the LTIP and the Co-Operation Agreement between
the Company and Takeda Pharmaceutical Company Limited
("Takeda") dated May 8, 2018:
1. vesting of the PSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of PSUs vesting was reduced to reflect the
accelerated date of vesting relative to the normal
vesting date and the achievement of applicable
performance conditions at a level of 87%;
3. the number of PSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting PSUs from the award
date to the date of vesting;
4. vesting of the PSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
--- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
--- ----------------------------- ----------------------- ---------------------------------------
c) Price(s) and volume(s) $ 0 4,466
--- ----------------------------- ------- -------------- ---------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
--- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
--- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
--- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
7. where transactions have been conducted
--- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
---
a) Identification code ISIN: US82481R1068
--- ----------------------------- ----------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 10, 2017. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
--- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
--- ----------------------------- ----------------------- ---------------------------------------
c) Price(s) and volume(s) $ 0 418
--- ----------------------------- ------- -------------- ---------------------------------------
Aggregated information
d) - Aggregated volume - Price N/A (single transaction)
--- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
--- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
--- ----------------------------- ----------------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
8. where transactions have been conducted
--- -----------------------------------------------------------------------------------------------
Description of the financial
instrument, type of
instrument Shire plc American Depositary Shares ("ADSs")
---
a) Identification code ISIN: US82481R1068
--- ----------------------------- ----------------------------------------------------------------
Vesting of Restricted Stock Units ("RSUs") awarded
under the Shire Deferred Bonus Plan 2015 ("DBP") on
March 9, 2018. In accordance with the rules of the
DBP and the Co-Operation Agreement between the Company
and Takeda Pharmaceutical Company Limited ("Takeda")
dated May 8, 2018:
1. vesting of the RSUs was accelerated relative to the
normal vesting date resultant of the Royal Court of
Jersey's sanctioning of the scheme of arrangement
governing the acquisition of the Company by Takeda;
2. the number of RSUs vesting was increased by an amount
equivalent to the value of dividends paid by the
Company in respect of the vesting RSUs from the award
date to the date of vesting;
3. vesting of the RSUs is to be satisfied in cash in an
amount per ADS of $173.17, net of any necessary
b) Nature of the transaction deductions for tax and social security contributions.
--- ----------------------------- ----------------------------------------------------------------
Price(s) Volume(s)
--- ----------------------------- ----------------------- ---------------------------------------
c) Price(s) and volume(s) $ 0 924
--- ----------------------------- ------- -------------- ---------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume - Price
--- ----------------------------- ----------------------------------------------------------------
e) Date of the transaction January 3, 2019
--- ----------------------------- ----------------------------------------------------------------
f) Place of the transaction N/A
--- ----------------------------- ----------------------------------------------------------------
For further information please contact:
Investor Relations
Christoph Brackmann christoph.brackmann@shire.com +41 41 288 41 29
Sun Kim sun.kim@shire.com +1 617 588 8175
Scott Burrows scott.burrows@shire.com +41 41 288 4195
Media
Katie Joyce kjoyce@shire.com +1 781 482 2779
NOTES TO EDITORS
Shire is now part of Takeda.
https://www.globenewswire.com/Tracker?data=QTJyGLlBDXAlCdGi9ng8C8zXTYLzxb8nc5RW8QI6y1qGqr3ra-a8bLgECDN0-z-yKFJ23yX_xx58SN3c4m3wmg==
www.takeda.com
www.shire.com
(END) Dow Jones Newswires
January 08, 2019 12:45 ET (17:45 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Shire (LSE:SHP)
Historical Stock Chart
From Oct 2024 to Nov 2024
Shire (LSE:SHP)
Historical Stock Chart
From Nov 2023 to Nov 2024
